These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37328006)

  • 1. Controlling release from encapsulated drug-loaded devices: insights from modeling the dissolution front propagation.
    Jain A; King D; Pontrelli G; McGinty S
    J Control Release; 2023 Aug; 360():225-235. PubMed ID: 37328006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A general model of coupled drug release and tissue absorption for drug delivery devices.
    McGinty S; Pontrelli G
    J Control Release; 2015 Nov; 217():327-36. PubMed ID: 26390809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for the Analysis of Membrane-Type Dissolution Tests for Inhaled Drugs.
    Frenning G; van der Zwaan I; Franek F; Fransson R; Tehler U
    Mol Pharm; 2020 Jul; 17(7):2426-2434. PubMed ID: 32463245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug diffusion and release from a bioerodible spherical capsule.
    Jain A; McGinty S; Pontrelli G
    Int J Pharm; 2022 Mar; 616():121442. PubMed ID: 34990743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical investigation of drug release from planar matrix systems: effects of a finite dissolution rate.
    Frenning G
    J Control Release; 2003 Oct; 92(3):331-9. PubMed ID: 14568413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of diffusion controlled drug delivery.
    Siepmann J; Siepmann F
    J Control Release; 2012 Jul; 161(2):351-62. PubMed ID: 22019555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Numerical modelling and experimental investigation of drug release from layered silicone matrix systems.
    Snorradóttir BS; Jónsdóttir F; Sigurdsson ST; Thorsteinsson F; Másson M
    Eur J Pharm Sci; 2013 Jul; 49(4):671-8. PubMed ID: 23684932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling of drug dissolution.
    Siepmann J; Siepmann F
    Int J Pharm; 2013 Aug; 453(1):12-24. PubMed ID: 23618956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modelling of the release of drug from porous, nonswelling transdermal drug-delivery devices.
    Lee AJ; King JR; Hibberd S
    IMA J Math Appl Med Biol; 1998 Jun; 15(2):135-63. PubMed ID: 9661281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics.
    Tzafriri AR; Parikh SA; Edelman ER
    J Control Release; 2019 Sep; 310():94-102. PubMed ID: 31430500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Dissolution Method for Oral Film Preparations with Modified Release Properties.
    Speer I; Preis M; Breitkreutz J
    AAPS PharmSciTech; 2018 Dec; 20(1):7. PubMed ID: 30560468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release.
    Park ES; Maniar M; Shah JC
    J Control Release; 1998 Mar; 52(1-2):179-89. PubMed ID: 9685948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion model for drug release from suspensions I: theoretical considerations.
    Ayres JW; Lindstrom FT
    J Pharm Sci; 1977 May; 66(5):654-62. PubMed ID: 874746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Initial Drug Distribution in Spherical Capsules for Personalized Release.
    Jain A; Subbarao K; McGinty S; Pontrelli G
    Pharm Res; 2022 Oct; 39(10):2607-2620. PubMed ID: 36071351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
    Salehi N; Kuminek G; Al-Gousous J; Sperry DC; Greenwood DE; Waltz NM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2021 Sep; 18(9):3326-3341. PubMed ID: 34428047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method.
    Pillay V; Fassihi R
    J Control Release; 1998 Oct; 55(1):45-55. PubMed ID: 9795013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant.
    Iqbal A; Zaman M; Wahab Amjad M; Adnan S; Abdul Ghafoor Raja M; Haider Rizvi SF; Mustafa MW; Farooq U; Abbas G; Shah S
    Int J Nanomedicine; 2020; 15():5603-5612. PubMed ID: 32848390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward Developing Discriminating Dissolution Methods for Formulations Containing Nanoparticulates in Solution: The Impact of Particle Drift and Drug Activity in Solution.
    Arce FA; Setiawan N; Campbell HR; Lu X; Nethercott MJ; Bummer P; Su Y; Marsac PJ
    Mol Pharm; 2020 Nov; 17(11):4125-4140. PubMed ID: 32965123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.